LMNTIC Blog
The science of isolating cancer's rarest cells
LMNTIC develops L:Biopsy — a platform for one-step, ultra-pure isolation of circulating tumor cells (CTCs) from whole blood, built on our Cell Circuit technology. This is where we write about the science, the engineering, and the people behind it.
-
Why MRD flags recurrence but can't guide treatment
As tumor burden falls, ctDNA drops below the level needed to genotype — so MRD tests detect that cancer is back, but not what to treat it with. With an interactive model.
-
Welcome to the LMNTIC blog
What we'll write about here — circulating tumor cells, the Cell Circuit, and building liquid biopsy from whole blood.